Fig. 1 Organelle-Targeted Liposome banner

Organelle-Targeted Liposome System Design

Liposomes can be engineered not just to enter cells, but to home to specific organelles—mitochondria, lysosomes, endoplasmic reticulum (ER), Golgi, or nucleus—so that bioactive payloads act where biology happens. Creative Biolabs designs organelle-targeted liposome systems that bring intracellular precision to your research.

Trusted by Industry Leaders

Leading biopharma and academic teams rely on Creative Biolabs for formulation science, ligand conjugation, and advanced intracellular targeting analytics.

Partner logo 1 Partner logo 2 Partner logo 3 Partner logo 4 Partner logo 5
Binding of liposomes to the target cell
Fig. 1 Binding of liposomes to the target cell2

Why Organelle-Targeted Liposome Design Matters

Most intracellular targets reside inside organelles. Delivering payloads to the right compartment improves potency in model systems, reduces off-target effects, and clarifies mechanism. Modern strategies combine organelle-addressing ligands—such as triphenylphosphonium for mitochondria, morpholine or mannose-6-phosphate for lysosomes, and nuclear localization signals for the nucleus—with stimuli-responsive membranes and validated colocalization analytics to confirm where cargo actually goes.

Custom Organelle Targeting Strategies

  • Mitochondria: Lipid-anchored cations like triphenylphosphonium accumulate payloads by leveraging the mitochondrial membrane potential.
  • Lysosome: Weak-base motifs such as morpholine and mannose-6-phosphate (M6P) conjugates exploit acid trapping or receptor-mediated uptake.
  • Nucleus: NLS-bearing peptides guide liposomes through the nuclear pore complex when size and timing are optimized.
  • ER/Golgi: ER-retention sequences and small-molecule Golgi probes are adapted into conjugation scaffolds to direct liposomes to these compartments.

Ligands are installed by orthogonal chemistries—maleimide–thiol coupling, copper-free click chemistry (SPAAC), or CuAAC under chelated conditions—balancing conjugation yield, ligand orientation, and membrane integrity.

  • Stimuli-responsive bilayers: DOPE/CHEMS compositions destabilize in acidic compartments, accelerating release.
  • Endosomal escape boosters: Fusogenic peptides and buffering lipopolymers help transfer cargo into the cytosol before organelle entry.
  • Cargo matching: Hydrophilic payloads use aqueous core loading, hydrophobic compounds partition into the bilayer, and sensitive macromolecules may require cleavable linkers.

Creative Biolabs doesn’t stop at uptake. We quantify organelle targeting with confocal colocalization (Pearson’s and Manders’ coefficients with thresholding controls) and subcellular fractionation followed by western blotting against canonical markers (e.g., COX IV for mitochondria; LAMP1 for lysosome; calnexin for ER; GM130 for Golgi; histone H3 for nucleus).

Service Scope and Capabilities

Module Key Features Representative Approaches
Organelle-Specific Targeting Modules Tailored liposomes designed to accumulate in specific organelles
  • Mitochondria: Triphenylphosphonium (TPP) cations, membrane potential-driven accumulation
  • Lysosome: Morpholine or Mannose-6-phosphate conjugates
  • ER/Golgi: ER-retention motifs, Golgi-affine scaffolds
  • Nucleus: Nuclear localization signal (NLS) peptides
Advanced Conjugation & Formulation Broad bioconjugation chemistry and formulation control
  • SPAAC (strain-promoted azide–alkyne cycloaddition)
  • CuAAC with chelation conditions
  • Maleimide–thiol coupling
  • Microfluidic or thin-film fabrication
Quantitative Targeting Analytics Rigorous validation of organelle localization
  • Imaging: Confocal microscopy with colocalization coefficients
  • Biochemistry: Subcellular fractionation + marker western blots
  • Functional readouts: Endosomal escape assays, pH reporters, mitochondrial potential probes

Service Workflow

1

Project Consultation

Define organelle, model, and research goals.

2

Design Blueprint

Select ligands, lipids, and escape strategies.

3

Prototype Fabrication

Liposome formulation and ligand installation.

4

Characterization

DLS, zeta potential, encapsulation efficiency, stability.

5

Validation

Confocal colocalization, fractionation, and functional assays.

6

Optimization & Reporting

Refine composition and deliver complete data package.

Deliverables

  • Detailed formulation dossier with lipid composition and methods.
  • QC report with DLS, PDI, zeta potential, and encapsulation efficiency.
  • Targeting evidence including imaging, colocalization analysis, and fractionation data.
  • SOPs for ligand conjugation and analytics.
  • Consultation summary with optimization insights.

All services are strictly For Research Use Only. Not For Clinical Use.

Advantages of Our Service

Expertise in advanced lipid modification and conjugation chemistries

Broad range of targeting ligands for mitochondria, lysosomes, ER, and nuclei

High reproducibility and scalability from pilot to research-grade production

Integrated analytical platforms for rigorous quality assessment

Flexible customization to meet diverse research needs

Applications of Organelle-Specific Liposomes

Mitochondrial research

Delivery of probes or nucleic acids for respiration, mitophagy, or ROS studies.

Lysosomal biology

Delivery of substrates or reporters to study degradation kinetics and pH dynamics.

ER stress and proteostasis

Target ER with unfolded-protein-response reporters or modulators.

Golgi trafficking

Explore glycosylation and cargo sorting with Golgi-targeted carriers.

Nuclear delivery studies

Introduce ribonucleoproteins or dyes with NLS-assisted entry to assess nuclear import.

Frequently Asked Questions

Organelle-targeted liposomes are engineered nanoparticles modified with ligands like TPP or NLS to deliver agents directly into mitochondria, nucleus, or lysosomes for precise intracellular delivery.

Other Resources

References

  1. Sanchez-Aranguren, Lissette, et al. "Mitochondrial-targeted liposome-based drug delivery–therapeutic potential and challenges." Journal of Drug Targeting 33.5 (2025): 575-586. https://doi.org/10.1080/1061186X.2024.2437440
  2. Rommasi, Foad, and Neda Esfandiari. "Liposomal nanomedicine: applications for drug delivery in cancer therapy." Nanoscale research letters 16.1 (2021): 95. https://doi.org/10.1186/s11671-021-03553-8 (Distributed under Open Access license CC BY 4.0, without modification.)
  3. Yang, Jingjing, et al. "Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology." Signal transduction and targeted therapy 7.1 (2022): 379. https://doi.org/10.1038/s41392-022-01243-0
  4. Tang, Wilson, et al. "Design principles and biomedical applications of endoplasmic reticulum-targeting luminescent nanoparticles." Nano Research 18.6 (2024). https://doi.org/10.26599/NR.2025.94907356

Online Inquiry

For Research Use Only. Not For Clinical Use.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Close
Thanksgiving
Thanksgiving